Sonic Incytes Selected for MedTech Innovator US 2021 Road Tour
Identified as best-in-class, Sonic Incytes Medical Corp. has been selected to pitch in the virtual MedTech Innovator US 2021 Road Tour on April 14, 2021. Every year, MedTech Innovator selects the best and brightest medtech start-ups that are seeking to improve patient lives through innovation. Sonic Incytes was selected to pitch among the more than 1000 […]
Sonic Incytes Recognized as a Ready to Rocket Company For Second Year in a Row
Recognized for its growth potential, Sonic Incytes Medical Corp. has been named a top technology company in the 19th Annual “Ready to Rocket” list published by Rocket Builders. Ready to Rocket is a unique business recognition list that profiles technology companies with the greatest potential for growth. Each year, based on analysis of trends, Rocket […]
Live Webinar: Redefining the Standard of Care for Assessing Liver Health
Sonic Incytes Medical Corp. is pleased to host a live educational webinar on Redefining the Standard of Care for Assessing Liver Health. Join presenters Dr. Tim Salcudean and Dr. Robert Rohling, leading experts and inventors in medical ultrasound imaging, to learn about: The Power of 3D Elastography in Measuring Liver Fibrosis How and Why Ultrasound […]
Sonic Incytes Selected for MedTech Innovator Asia Pacific 2021 Road Tour
Acknowledged for our mission to improve patient lives, Sonic Incytes Medical Corp. has been selected to pitch in the virtual MedTech Innovator Asia Pacific 2021 Road Tour on March 23, 2021 (PT). MedTech Innovator Asia Pacific is the premier competition for emerging medtech companies in the Asia Pacific region. Every year, MedTech Innovator selects the […]
Our Co-Founders’ Story: Paving the Way for a New Standard of Care in Assessing Liver Health
It takes a certain type of person to be painstakingly driven to seek novel ways of making the impossible possible. Someone who is constantly curious, has grit, and loves to solve problems. Drs. Tim Salcudean and Robert Rohling, co-founders of Sonic Incytes Medical Corp., have these characteristics in spades. Salcudean and Rohling are leading experts […]
Sonic Incytes Selected as an Alternate in 2021 SXSW Pitch
Sonic Incytes Medical Corp., the developers of the first handheld 3D liver health assessment solution, was selected as an alternate in the Health, Wearables & Wellbeing category for the 13th annual SXSW Pitch, March 17-18, 2021. SXSW Pitch is a marquee event where leading start-ups from around the world showcase some of the most innovative […]
Visit VelacurTM at NASH-TAG 2021
Discover how fast, accurate and easy VelacurTM is to assess liver health at the NASH-TAG Conference, March 11-13, 2021. Read our poster and visit our in-person booth for live demos of Velacur, the first handheld 3D liver health assessment solution. Developed by Sonic Incytes Medical Corp., VelacurTM is a breakthrough, point of care ultrasound solution that […]
Live Webinar: The Role of Next-Gen NITs in NAFLD/NASH
Sonic Incytes Medical Corp. is pleased to host a live educational webinar on The Role of Next-Gen Non-Invasive Tests (NITs) in NAFLD/NASH. Join presenter Dr. Robert Gish, a renowned hepatologist and gastroenterologist, to learn about: Non-Invasive Tests (NITs) for Detecting NAFLD/NASH Role of NITs in Staging Fibrosis & Quantifying Steatosis Best Practices for Integrating NITs […]
Further Studies Underway to Demonstrate Clinical Value of VelacurTM
Sonic Incytes is proud to expand its collaboration with key centers of clinical excellence in chronic liver disease in North America to continue evaluating its diagnostic solution, VelacurTM. Indiana University (IU) has recently joined Sonic Incytes’ Early Access Program to trial VelacurTM. IU aims to evaluate VelacurTM in comparison to other methods in assessing non-alcoholic […]
Sonic Incytes Introduces VelacurTM at 2021 Digital Medicine & Medtech Showcase
Sonic Incytes Medical Corp. is pleased to present its breakthrough liver health assessment solution, VelacurTM, at the Digital Medicine & Medtech Showcase 2021, part of Biotech Showcase™ 2021 and during the 39th Annual JP Morgan Healthcare Conference, taking place the second week of January. Affecting 100 million Americans by 2030, and millions more around the […]
